The impact of self-reported cumulative comorbidity on stroke recovery SIR-Comorbid disease is common in stroke survivors but studies of stroke recovery have rarely identiWed comorbid conditions as predictors [1] [2] [3] [4] [5] [6] [7] Comorbid health problems consistently affect survival and utilisation regardless of condition, and have modest associations with concurrent functional status, but comorbid illness and function have independent effects on survival and utilisation [8] [9] [10] [11] [12] . The severity of comorbid illnesses may be measured in part by impact on activity and function [8, [13] [14] [15] [16] [17] [18] , producing conceptual and analytic overlap in measures of comorbidity and function. In inpatient rehabilitation settings, where baseline functional status predicts recovery, comorbid illness has a modest and inconsistent effect on outcome [1, 9, 19, 20] . The effect of self-reported comorbid burden on stroke recovery after discharge from institutional settings is not known. This study examines the effect of comorbid burden of disease, independent of stroke severity, age and function, on stroke recovery over 6 months.
Methods

Overview
This is a prospective cohort study of stroke survivors in the Kansas City Stroke Study (KCSS). The protocol was approved by the Institutional Review Board. All subjects were seen within 2 weeks after stroke, and reassessed at 1, 3 and 6 months at their residence. A full description of study methods has been published [2] and is summarised here.
Subjects
The KCSS recruited stroke survivors from 12 participating hospitals within the Wrst 14 days since stroke (median 8 days). An eligible stroke was deWned by the WHO criteria and was conWrmed by clinical assessment and/or by a CT/MRI scan. The comorbidity index was introduced into this study after data collection had begun and was subsequently collected in all consecutive participants.
Procedures and measures
Assessments included baseline demographics, prior function, stroke characteristics, and general functional status measures [2] .
The Comorbidity Disease Index is a patient self-report measure which includes conditions that are relevant to rehabilitation. The 19 items were classiWed into eight domains, as shown in Table 1 . Since stroke was the primary diagnosis, it was excluded as a comorbidity. The comorbid burden score is the sum of involved domains. When Wrst developed, the comorbidity scale included degree of limitation attributed to each condition to reXect severity. Since limitation is related to function, and because limitation did not increase explained variance in our prior analyses with both baseline function and comorbid burden, we did not include severity in the score [21] . Comorbidity self-reports were collected at the baseline interview of patients and/or proxies (8.7% by proxy).
Risk factors for stroke were abstracted from the medical record using a structured tool. Conditions that were col- lected from both the self-report and the chart abstraction, including heart attack, congestive heart failure and diabetes, were used to assess agreement rates. We chose three indicators of functional status: basic activities of daily living using the Barthel index,with a cutoff of 95 or higher for independence [22] , instrumental activities of daily living (IADL) using the Lawton-Brody scale [23] , and physical function using the Physical Function subscale from the SF-36 [24, 27] .
The Orpington Prognostic Scale (OPS) is a general measure of stroke severity that includes measures of motor deWcit, proprioception, balance and cognition [28, 29] . The NIH Stroke Scale is a 13-item assessment tool of neurological deWcits due to stroke [30] .
Analysis
Comorbidity scores were assessed in three levels: 1) one or fewer domains, 2) two domains and 3) three or more domains. The Chi-square test and one-way ANOVA were used to compare outcomes across the three levels. Linear multiple regression was used to assess the impact of comorbid burden both as an ordinal scale with three levels (0-1, 2 and 3) and in individual comorbidity domains coded as indicator variables, on the three main outcomes after adjusting for age, baseline function and stroke severity. Logistic regression was used similarly for the categorical Barthel independence outcome.
Results
The comorbidity scale was begun in the study about halfway through recruitment. Of 459 participants in the KCSS, the last 236 who had comorbidity reports and survived at 3 months post stroke were included in this study. See Table 1 for characteristics of the participants. Within the KCSS population, participants in this sub-study, compared to the non-participants, were similar in most characteristics, including demographics, functional status by baseline Barthel ADL score, Lawton-Brody IADL score and SF-36 and stroke severity by OPS, diabetes, CHF and MI. Participants had slightly higher rates of ischemic stroke (96% versus 90%), prior TIA (22% versus 12%) and peripheral vascular disease (20% versus 8%) than nonparticipants. Comorbid conditions were common, especially musculoskeletal, generalised symptoms, diabetes mellitus, and cardiovascular conditions, as shown in Table 1 . The median number of domains per person was two. Agreement rated between self-report and chart diagnosis for the three conditions ranged from 84% to 94%, with kappa statistics of 0.67, 0.56 and 0.63 for heart attack, congestive heart failure and diabetes, respectively.
All stroke survivors were assessed at 3 months and 218/236 (92%) were assessed at 6 months. Function tended to improve over time in all outcome measures. The proportion of participants who achieved a Barthel score ≥95 increased from 6.8% at baseline to 53% at 6 months. The mean score on the Lawton-Brody scale of IADL increased from 18 ± 5.2 to 19 ± 5.9. The mean score on the Physical Function subscale increased from 33 ± 27.7 to 43 ± 29.3. The burden of comorbid disease was a signiWcant univariate predictor of all functional outcomes at both 3 and 6 months ( Table 2) .
The independent effect of comorbid burden on the functional outcomes, after accounting for baseline status, age and stroke severity, is shown in Table 2 . Comorbid burden predicted independence in Barthel basic activities, LawtonBrody IADL and physical function at 3 but not at 6 months. No consistent patterns between individual comorbidity domains and functional outcomes were observed (data not shown). Age and baseline function were predictors in all models, while stroke severity was only sometimes a signiWcant factor.
Discussion
Comorbid burden has a powerful effect on functional outcome when used as a single predictor, but most of the predictive information is also captured in baseline functional status and age. The main additional explanatory power of comorbid burden appears earlier in the recovery process and dissipates by 6 months post stroke.
Many prior studies of functional recovery after stroke have failed to account for comorbidity, while studies of comorbid burden have failed to examine functional outcomes. Studies of the effect of comorbidity on functional recovery in stroke have been limited to institutional settings (1, 19, 20, (31) (32) (33) (34) (35) . Stineman et al. examined the effect of comorbidity on outcomes in a secondary analysis of discharges from inpatient rehabilitation services. When using comorbidity weights based on expert physiatrist opinions, an effect was found on length of stay, but only minimally on functional recovery [31, 32] . The authors suggested that the modest effects of comorbidity might be due to incomplete discharge diagnosis coding, lack of disease severity coding or to the dominance of functional status on recovery. When using the Cumulative Illness Rating Scale in a rehabilitation unit, comorbid burden affected functional gain and rehabilitation efWciency, after controlling for admission functional status. Increased length of stay and decreased rehabilitation efWciency are consistent with our Wndings that higher levels of comorbidity may delay recovery. This study used self-report of conditions. Some important conditions that are asymptomatic may be under-recognised using self-report. Other conditions, like pain or sleep disorders, may be under-recognised using medical records. Comorbidity indices based on medical record reviews can be expensive, time-consuming, and require professional judgment, whereas self-report of conditions are more feasible and capture conditions that may be missed in medical records [36, 37] . Disease severity may be captured in part by impact on function, which is available by self-report. In a study of selfreport versus medical record review of Charlson Comorbidity score items, Katz et al. found agreement rates over 90% and equivalent capacity to predict utilization [36] .
This study does not compare the comorbidity scale used here to other comorbidity scales. Since it is a self-report survey, it is likely that more complex and time-consuming scales would have at least as much, if not more explanatory power. We did not account for severity of illness other than as it impacted function because we had previously found that severity and functional limitations are closely related [21] . Comorbid impacts on function described here are general, but actual effects may be speciWc to unique disease pairs [38] .
Stroke recovery may be delayed by comorbid burden, through slower progress, service interruptions due to exacerbations of coexisting diseases or increased vulnerability to medical complications. This delay in recovery has implications for research and practice. The comorbid burden might affect the optimal time points to assess outcomes in research studies. Clinically, optimal management of comorbid conditions might accelerate recovery. Alternately, comorbid burden might provide predictions about the time course of recovery for providers and patients. 
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